MarketCap
Facebook
X
TelegramQuidel Corporation General and Administrative Expenses 2011-2026 | QDEL
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Quidel Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 66.6 M | 164 M | 154 M | 96.4 M | 74.9 M | 77.3 M | 67.3 M | 60.1 M | 51 M | 48.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 164 M | 48.5 M | 86 M |
General and Administrative Expenses of other stocks in the Diagnostics research industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
490 M | $ 17.35 | -6.52 % | $ 183 M |  China |
 |
Centogene N.V.
CNTG
|
46.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
9.06 M | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Castle Biosciences
CSTL
|
229 M | $ 19.26 | 1.99 % | $ 558 M | USA |
 |
Fulgent Genetics
FLGT
|
88.1 M | $ 16.02 | -1.05 % | $ 484 M | USA |
 |
Agilent Technologies
A
|
1.62 B | $ 112.14 | -0.98 % | $ 34.1 B | USA |
|
Akumin
AKU
|
2.08 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
7.96 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
39.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
1.09 B | $ 140.19 | -2.13 % | $ 22.3 B | USA |
 |
Biocept
BIOC
|
16.1 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
22.3 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
9.48 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
108 M | $ 20.04 | -2.22 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
275 M | $ 94.57 | -2.18 % | $ 6.38 B | USA |
 |
Check-Cap Ltd.
CHEK
|
2.37 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
15.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
198 M | $ 420.05 | 0.21 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
998 M | $ 1 048.98 | 0.68 % | $ 21.6 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
257 M | $ 3.62 | - | $ 335 M | USA |
 |
Global Cord Blood Corporation
CO
|
187 M | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
273 M | $ 8.3 | -0.72 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
97.9 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
126 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
43.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
743 M | $ 158.51 | -0.5 % | $ 7.86 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
453 M | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
54.8 M | $ 19.0 | 0.37 % | $ 425 M | USA |
 |
Natera
NTRA
|
589 M | $ 185.77 | -5.66 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
21.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
628 M | $ 25.23 | -1.1 % | $ 23.9 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
889 M | - | - | $ 19.8 B | USA |
 |
Senseonics Holdings
SENS
|
52.5 M | $ 5.84 | 0.34 % | $ 244 M | USA |
 |
Guardant Health
GH
|
211 M | $ 95.26 | -3.45 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
53.6 M | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Heska Corporation
HSKA
|
64.1 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
585 M | $ 118.21 | 0.96 % | $ 9.75 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
132 M | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
128 M | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
247 M | $ 49.69 | -6.16 % | $ 2.97 B | USA |
 |
Biomerica
BMRA
|
2.98 M | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.22 B | $ 251.84 | -0.89 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
8.73 B | $ 441.44 | -1.5 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.8 M | $ 0.59 | 1.42 % | $ 212 M | Irlanda |
 |
Celcuity
CELC
|
27.2 M | $ 132.6 | -1.57 % | $ 6.2 B | USA |
 |
Motus GI Holdings
MOTS
|
6.58 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
240 M | $ 332.1 | -0.33 % | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
218 M | $ 8.36 | -0.83 % | $ 1.81 B | USA |